ScrutarSign up free

INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF)

SEC filings, insider trading & institutional ownership from EDGAR.

NYSEMaterialsChemicals

IFF (International Flavors & Fragrances) is a leading creator and manufacturer of products for food, beverage, health and biosciences, and scent applications, along with complementary adjacent products such as natural health ingredients. Its products are used in a wide variety of consumer and end-use products, and the company holds global leadership positions in the Food & Beverage, Home & Personal Care and Health & Wellness markets. Sales in 2025 were $10.890 billion.

During 2025 the business had four continuing segments: Taste, Food Ingredients, Health & Biosciences and Scent. A fifth segment, Pharma Solutions, was part of the business until its divestiture in May 2025, together with the nitrocellulose disposal group. Effective January 1, 2025, the former Nourish segment was split into Taste and Food Ingredients. Taste develops flavor compounds and natural taste solutions for savory products, beverages, sweets and dairy, and includes spices and seasoning ingredients. Food Ingredients offers natural, artificial and plant-based specialty ingredients, including soy and pea proteins, emulsifiers, sweeteners, natural food protection ingredients, savory solutions and inclusion products. Health & Biosciences produces enzymes, food cultures, probiotics and specialty ingredients through its Health, Food Biosciences, Home & Personal Care, Animal Nutrition and Grain Processing units. Scent creates fragrance compounds for fine fragrance and consumer products (fabric care, home care and body care) and fragrance ingredients, which are used internally and sold to third parties, including competitors.

Customers are mainly manufacturers of dairy, meat, beverages, snacks, savory and sweet goods, baked goods, personal care products, soaps and detergents, cleaning products, perfumes, dietary supplements, infant, elderly and animal nutrition, functional food, biofuel and oral care products. Sales are geographically diverse: the U.S. accounted for about 28% of 2025 sales and no other country exceeded 10%. No customer represented 10% or more of sales. Some large customers limit their supplier lists through "core lists," and private label manufacturers are a growing customer segment.

IFF relies on research and development, with about 3,000 employees in R&D, 849 granted U.S. patents and principal R&D sites in Union Beach (NJ), Wilmington (DE), Palo Alto (CA), Brabrand (Denmark) and Leiden (The Netherlands). It sources about 20,000 raw materials, natural and synthetic, from domestic and international suppliers. It operates about 170 manufacturing facilities, creative centers and application laboratories in about 30 countries, and has roughly 21,500 employees. Its main competitors include Givaudan, Novonesis, DSM-Firmenich, Symrise, Kerry and ADM, as well as mid-sized, regional and local manufacturers and consumer product companies that develop their own products. Its operations are subject to food, chemical, environmental and workplace safety regulation. Principal executive offices are in New York, New York and Wilmington, Delaware.

AI-summarized from Item 1 (Business) of the company’s most recent 10-K filing.

RevenueFY2025
$10.89B
▼ 5.2%YoY
Net incomeFY2025
-$361M
▼ 248.6%YoY
Diluted EPSFY2025
-$1.41
▼ 248.4%YoY
Gross margin
36.2%
▲ 25 bpsYoY
Insider net6 mo
+258.0K
shares3 sells2 buys
Institutions
51
$12.87B held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
-$5B$5B$10B$15B
FY2022FY2023FY2024FY2025
RevenueNet income
FY2025 highlightsfrom 10-K
Gross profit$3.94B
Operating income-$382M
Diluted EPS-$1.41
Gross margin36.2%
Net margin-3.3%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
10-QNov 3, 2026EDGAR
8-KNov 3, 2026EDGAR
8-KNov 3, 2026EDGAR
4Teles de Mendonca Ana PaulaAug 19, 2026EDGAR
4Birenkrant MarcAug 10, 2026EDGAR
4DeVeau MichaelAug 7, 2026EDGAR
8-KAug 4, 2026EDGAR
10-QAug 4, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
Teles de Mendonca Ana PaulaAug 17, 2026Sell
Birenkrant MarcAug 7, 2026Sell
DeVeau MichaelAug 6, 2026Sell
FRIBOURG PAUL JJun 1, 2026Buy
FRIBOURG PAUL JJun 1, 2026Buy

Top holders

13F & 13D/G • latest quarter

All →
HolderStakeFiledValue
Dodge & Cox14.8%Aug 13, 2026$2.93B
BlackRock, Inc.9.3%Aug 7, 2026$1.84B
Vanguard Capital Management6.5%Aug 13, 2026$1.29B
STATE STREET CORPORATION4.9%Sep 22, 2026$982.39M
Vanguard Portfolio Management4.6%Aug 13, 2026$919.64M

IFF's filings are public. The insight is one click away.

Scrutar's AI reads every IFF filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze IFF filingsNo credit cardAI reports included on the free plan

Never miss a IFF filing.

Get an email when IFF files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Nov 8, 2026Source: SEC EDGAR.